Original PDF Viewer

This embedded PDF preserves figures, tables, images, and layout.

Searchable Extracted Text

Page 1
CE Test
Pharmaceutical Advertising: The Cost for Fantasy Over Reality
Evidence for the Prescribing Clinical Nurse Specialist
Instructions:
-  Read the article. The test for this CE activity can only be
taken online at http://www.nursingcenter.com/ce/CNS.
Tests can no longer be mailed or faxed.
-  You will need to create (its free!) and login to your
personal CE Planner account before taking online tests.
Your planner will keep track of all your Lippincott Professional
Development online CE activities for you.
-  There is only one correct answer for each question. A
passing score for this test is 12 correct answers. If you
pass, you can print your certificate of earned contact
hours and access the answer key. If you fail, you have the
option of taking the test again at no additional cost.
-  For questions, contact Lippincott Professional Development:
1-800-787-8985.
Registration Deadline: June 4, 2021
Disclosure Statement:
The author and planners have disclosed no potential conflicts of
interest, financial or otherwise.
Provider Accreditation:
Lippincott Professional Development will award 1.0 contact
hour for this continuing nursing education activity.
Lippincott Professional Development is accredited as a provider
of continuing nursing education by the American Nurses
Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California
Board of Registered Nursing, Provider Number CEP 11749
for 1.0 contact hour. Lippincott Professional Development is
also an approved provider of continuing nursing education by
the District of Columbia and Florida, CE Broker #50-1223.
Payment:
-  The registration fee for this test is $12.95.
CE TEST QUESTIONS
PURPOSE: To provide information on direct-to-consumer pharmaceutical
advertising (DTCPA).
LEARNING OBJECTIVES/OUTCOMES: After completing this continu
ing education activity, you should be able to:
1. Outline trends in DTCPA since 1997.
2. Identify DTCPA techniques as well as advantages and disadvantages of this
marketing strategy.
1. Between 1997 and 2016, advertisements increased in number from
79,000 to
a. 560,000.
c. 4.6 million.
b. 2.1 million.
2. In 2016, the greatest amount of DTCPA money was spent on
prescription drugs to treat
a. diabetes/endocrine.
c. pain/central nervous system disorders.
b. cardiac.
3. In 2011, it was estimated that the average consumer viewed up to
how many hours of DTCPA per year?
a. 15
c. 45
b. 30
4. The Food and Drug Administration (FDA) does not allow DTCPA
of any of the following except
a. an off-label promotion.
b. a drug that received accelerated approval by the FDA.
c. a drug for an indication not approved by the FDA.
5. Because of change to over-the-counter access or loss of patent
protection, over the past 20 years there has been significant decline
in advertising for medication for
a. cholesterol.
c. depression.
b. impotence.
6. In a 2018 study by Klara et al of all English-language ads aired in the
United States from January 2015 to July 2016, what percentage of
ads provided a quantitative report of drug risks?
a. 0
b. 11%
c. 19%
7. What percentage of DTCPA in the study of Klara et al (2018)
provided a numeric description of drug efficacy?
a. 14%
c. 38%
b. 26%
CNS0719
8. In the 2018 study of Klara et al, 13% of the ads were labeled as
suggesting off-label use for weight loss and
a. lowering hemoglobin A1c.
c. reducing blood pressure.
b. improving sleep quality.
9. The most common ads from the study of Klara et al (2018) were for
a. inflammatory conditions.
c. allergic reactions.
b. bowel and bladder dysfunction.
10. As noted in the article, to increase the persuasive impact of an ad message,
the promotional element of any DTCPA has primary emphasis on
a. rational ingredients.
b. cognitive ingredients.
c. emotional ingredients.
11. What does the author note are blended within the ad's visual elements
of fantasy, sexual appeal, youth, happiness, and success?
a. cost
b. dosing information
c. risk and adverse effects
12. The only country besides the United States that permits DTCPA is
a. New Zealand.
b. Germany.
c. Argentina.
13. The author reports that advantages of DTCPA include
a. lower drug prices.
b. decreased stigma of disease.
c. healthcare provider accountability.
14. Disadvantages of DTCPA noted in the article include a lack of
a. consumer feedback.
b. clarity on the drug's generic name.
c. connection to comparable treatments.
15. The author suggests that DTCPA fuel
a. improved medical care.
b. research into new pharmaceuticals.
c. rising healthcare costs.
16. As noted in the article, current targets for DTCPA are
a. caregivers and children of aging parents.
b. viewers in the 18- to 30-year-old demographic.
c. physically active, middle-aged persons.
17. Prescription drug spending in the United States in 2016 accounted for
what percentage of health spending?
a. 10%
c. 20%
b. 15%
Clinical Nurse Specialist
E1
Copyright (c) 2019 Wolters Kluwer Health, Inc. All rights reserved.